NDC 0186-0777 – Brilinta
Ticagrelor 90 mg/1 · Tablet · Oral
Product NDC0186-0777
Product details
- Brand name
- Brilinta
- Generic name
- Ticagrelor
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA022433
- Marketed since
- August 5, 2011
- Listing expires
- December 31, 2027
- Pharmacologic class
- P2Y12 Platelet Inhibitor
Active ingredients
- Ticagrelor 90 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0186-0777-39 | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (0186-0777-39) / 10 TABLET in 1 BLISTER PACK | Aug 5, 2011 |
| 0186-0777-60 | 60 TABLET in 1 BOTTLE (0186-0777-60) | Aug 5, 2011 |
Recalls mentioning this NDC
- D-0433-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage. - D-0958-2017 Jul 19, 2017 · Class I
Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the expected…
Other Brilinta products
- 71610-815 Ticagrelor 90 mg/1 · Tablet · Aphena Pharma Solutions - Tennessee, LLC
- 0186-0776 Ticagrelor 60 mg/1 · Tablet · AstraZeneca Pharmaceuticals LP
- 55154-9618 Ticagrelor 90 mg/1 · Tablet · Cardinal Health 107, LLC